The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.71

Today's change+0.01 +1.43%
Updated September 4 2:40 PM EDT. Delayed by at least 15 minutes.
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.71

Today's change+0.01 +1.43%
Updated September 4 2:40 PM EDT. Delayed by at least 15 minutes.

Oncolytics Biotech Inc crosses above 20-day moving average

Oncolytics Biotech Inc is up today by $0.01 or 1.43% to $0.71 and crossing above its 20-day moving average. Shares have lost 6.58% over the last five days, but have gained 10.94% over the last year to date. This security has underperformed the S&P TSX by 36.01% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.16
Updated September 4 2:40 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue00--0
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4445
Selling / general / administrative0000
Research & development2334
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1111
Operating income-4-4-4-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-4-4-5
Income after tax-4-4-4-5
Income tax, total0000
Net income-4-4-4-5
Total adjustments to net income--------
Net income before extra. items-4-4-4-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-4-4-5
Inc. avail. to common incl. extra. items-4-4-4-5
Diluted net income-4-4-4-5
Dilution adjustment00--0
Diluted weighted average shares1151009189
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.04-0.04-0.05
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.04-0.04-0.05